INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F$90K
233 sh
Sep 5, 2026Sep 9, 2026
Page 378 of 1689
← PrevNext →
traded Sep 5, 2026
+4d
SEC Form 4

Evidence

30
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F$195K
504 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

30
PD
Phillips DominicSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$793K
17.9K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

30
PD
Phillips DominicSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$518K
11.7K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

29
MA
Merriman AndrewChief Operating Officer
CTMCastellum, Inc.
Open-market purchase
BUY$25K
40.0K sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

29
CG
Crook Nathaniel GlennChief Commercial Officer
AMPLAmplitude, Inc.
Open-market sale · 10b5-1 plan
SELL$3.90M
300.0K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

29
TO
Tepper OrenCRO
NYAXNayax Ltd.
Open-market sale
SELL$3,368
65 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

28
WB
Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER
MDRRMedalist Diversified, Inc.
Open-market purchase
BUY$96
8 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

28
WB
Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER
MDRRMedalist Diversified, Inc.
Open-market purchase
BUY$24
2 sh
Sep 2, 2026Sep 9, 2026
traded Sep 2, 2026
+7dSEC Form 4

Evidence

28
WB
Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER
MDRRMedalist Diversified, Inc.
Open-market purchase
BUY$24
2 sh
Sep 3, 2026Sep 9, 2026
traded Sep 3, 2026
+6dSEC Form 4

Evidence

28
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$1.30M
14.4K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

28
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$1.41M
16.1K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

28
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$190K
4,500 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

28
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$135K
1,590 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

28
MN
Meriweather Tiffany N.Chief Admin. & Legal Officer
FIVNFive9, Inc.
Open-market sale · 10b5-1 plan
SELL$262K
7,809 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
768 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

27
CD
Collins John DeNeenChief Financial Officer
SOUNSOUNDHOUND AI, INC.
Grant or award
A—
1.00M sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
768 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

27
RG
Ramdas GautamPresident and CEO
NTICNORTHERN TECHNOLOGIES INTERNATIONAL CORP
Grant or award
A—
43.8K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
ES
Evran SedatEVP, Global Supply Chain
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
864 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

27
MM
Mulshine Brendan MartinCo-President and CRO
RYANRYAN SPECIALTY HOLDINGS, INC.
Derivative conversion
C—
40.0K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$388K
4,564 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
685 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

27
AS
Allison SchwartzDirector
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
92 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

27
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
1,370 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

27
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$735K
12.9K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

27
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
685 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

27
SA
Stepak AvnerDirector
ETOReToro Group Ltd.
Derivative conversion
C—
33.8K sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

27
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
1,370 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

27
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
456 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

26
EA
Evans AichaDirector
JOBYJoby Aviation, Inc.
Gift
G—
24.6K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

26
WJ
Wassil JimEVP, Chief Scientific Ofc, COO
PCVXVaxcyte, Inc.
Open-market sale
SELL$84K
1,381 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

26
MA
Maguire Scott AndrewCOO
ONONOn Holding AG
Open-market sale
SELL$41K
1,475 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

26
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F$118K
305 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

26
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$225K
1,426 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

26
EC
Enloe Courtney CEVP, General Counsel & Sec
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F$95K
246 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

26
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$225K
1,426 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

25
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$631K
7,027 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

25
MN
Meriweather Tiffany N.Chief Admin. & Legal Officer
FIVNFive9, Inc.
Open-market sale · 10b5-1 plan
SELL$185K
5,600 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

25
YT
Yoon William TChief Legal Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$431K
12.4K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence